Abstract
Asthma is the most prevalent chronic inflammatory respiratory disease worldwide affecting one in twelve adults (8.3%) in the United Kingdom (UK) (1). Coronavirus disease 2019 (Covid-19) has afflicted at least 80.3 million patients worldwide (17.3 million in the EU, 2.3 million in the UK), and has resulted in more than 1.6 million deaths (427,000 in the EU, 71,000 in the UK) (European Centre for Disease Prevention and Control: 30/12/2020). It is still unclear how asthma affects Covid-19 related mortality with marked regional differences noted (2).
Highlights
Note: Data were analysed using chi-squared or Wilcoxon-Mann-Whitney test where appropriate. p Values
A total of 6638 patients were tested for COVID-19, whereby a larger proportion of patients with asthma (PWA) (914, 48%) were tested for COVID-19 compared with patients with no asthma (PWNoA) (5724, 27%)
A significantly larger proportion of the PWA tested positive for COVID-19 and a significantly greater proportion of them were admitted to the high dependency unit (HDU) (Table 1)
Summary
Note: Data were analysed using chi-squared or Wilcoxon-Mann-Whitney test where appropriate. p Values
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
